Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2022

21-03-2022 | Research article

Community-based lifestyle intervention improves metabolic syndrome and related markers among Kenyan adults

Authors: Okubatsion Tekeste Okube, Samuel Kimani, Waithira Mirie

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2022

Login to get access

Abstract

Purpose

Metabolic syndrome (MetS) is a major risk factor for cardiovascular diseases and type-2 diabetes. The study aimed to establish the efficacy of a community-based lifestyle intervention on MetS in Kenyan adults using randomized control trial involving a 15-months follow up.

Methods

A randomized controlled trial involving 352 (18–64 years old) adults with MetS spanning 15-months duration. Participants were recruited from a Nairobi based Mission-led outpatient clinic, randomly assigned equally into intervention and control groups. The intervention group was exposed to a community-based health education on lifestyle modification, while control group was subjected to hospital-led routine care involving treatment and general lifestyle advice. The study was structured into baseline, intervention and evaluation phases with inbuilt data collection in each phase. Physiologic, anthropometric, and clinical parameters as well lifestyle characteristics were measured at baseline, midline and end-line. The parameters were compared across the groups and between the time points during analyses using chi-square test, binary logistic, independent t-test and paired t-test.

Results

Proportion of participants with MetS declined significantly (p < 0.001) with marked (p < 0.05) improvement in markers of MetS (elevated BP, raised sugars, cholesterols, central obesity) in intervention compared to control group. The rates of consumption of fruits, vegetables, legumes, nuts and uptake of physical activity significantly (p < 0.05) improved in the intervention group. However, the intake of processed/fast foods, salt, sugar, and alcohol significantly (p < 0.05) declined in the intervention compared to controls by the end-line.

Conclusion

One in three adults under the community-based lifestyle intervention had improvement in physiologic, anthropometrics and clinical markers relevant to definition of MetS. Additionally, an improved adherence to the recommended dietary intake and increased uptake of physical activity in adults with MetS was observed. These findings underscore the feasibility, effectiveness and proof of concept for community-based lifestyle approach as a viable strategic intervention for addressing premorbid risk factors for cardiovascular CVDs and diabetes before evolving into full blown conditions in low-income settings.
Literature
1.
go back to reference Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629–36.CrossRef Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629–36.CrossRef
5.
go back to reference International Diabetic Federation (IDF). Diabetes ATLAS, Seventh Edition. 2015. International Diabetic Federation (IDF). Diabetes ATLAS, Seventh Edition. 2015.
6.
go back to reference O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12 Google Scholar.CrossRef O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12 Google Scholar.CrossRef
7.
go back to reference Kaduka LU, Kombe Y, Kenya E, Kuria E, Bore JK, Bukania ZN, Mwangi M. Prevalence of Metabolic Syndrome Among an Urban Population in Kenya. Diabetes J Diabetes Care. 2012;2012(35):887–93.CrossRef Kaduka LU, Kombe Y, Kenya E, Kuria E, Bore JK, Bukania ZN, Mwangi M. Prevalence of Metabolic Syndrome Among an Urban Population in Kenya. Diabetes J Diabetes Care. 2012;2012(35):887–93.CrossRef
8.
go back to reference Cantiello F, et al. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review. Int J Urol. 2015;22:22–32.CrossRef Cantiello F, et al. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review. Int J Urol. 2015;22:22–32.CrossRef
9.
go back to reference Mendonça FM, de Sousa FR, Barbosa AL, Martins SC, Araújo RL, Soares R, et al. Metabolic syndrome and risk of cancer: which link? Metabolism. 2015;64:182–9.CrossRef Mendonça FM, de Sousa FR, Barbosa AL, Martins SC, Araújo RL, Soares R, et al. Metabolic syndrome and risk of cancer: which link? Metabolism. 2015;64:182–9.CrossRef
12.
go back to reference Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70(1):3–21.CrossRef Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70(1):3–21.CrossRef
15.
go back to reference Samuel K, Mirie W, Chege M, Okube OT, Muniu S. Association of lifestyle modification and pharmacological adherence on blood pressure control among patients with hypertension at Kenyatta National Hospital, Kenya: a cross-sectional study. BMJ Open. 2019;9:e023995. https://doi.org/10.1136/bmjopen-2018-023995. Samuel K, Mirie W, Chege M, Okube OT, Muniu S. Association of lifestyle modification and pharmacological adherence on blood pressure control among patients with hypertension at Kenyatta National Hospital, Kenya: a cross-sectional study. BMJ Open. 2019;9:e023995. https://​doi.​org/​10.​1136/​bmjopen-2018-023995.
18.
go back to reference World health organization. Kenya faces rising burden of diabetes. Geneva: Switzerland; 2014. World health organization. Kenya faces rising burden of diabetes. Geneva: Switzerland; 2014.
20.
go back to reference World Health Organization. Global status report on non-communicable diseases. Geneva: Switzerland; 2014. World Health Organization. Global status report on non-communicable diseases. Geneva: Switzerland; 2014.
21.
go back to reference Al-Thani MH, Al-Thani AAM, Cheema S, Sheikh J, Mamtani R, Lowenfels AB, et al. Prevalence and determinants of metabolic syndrome in Qatar: results from a National Health Survey. BMJ Open. 2016;6:e009514.CrossRef Al-Thani MH, Al-Thani AAM, Cheema S, Sheikh J, Mamtani R, Lowenfels AB, et al. Prevalence and determinants of metabolic syndrome in Qatar: results from a National Health Survey. BMJ Open. 2016;6:e009514.CrossRef
22.
go back to reference Mohamed SA. Effect of lifestyle intervention on health behaviors, weight and blood glucose level among patients with diabetes mellitus. J Nurs Educ. 2014; Pract. 4 Mohamed SA. Effect of lifestyle intervention on health behaviors, weight and blood glucose level among patients with diabetes mellitus. J Nurs Educ. 2014; Pract. 4
23.
go back to reference Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med.2012; 10. Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med.2012; 10.
24.
go back to reference Makrilakis K, Grammatikou S, Liatis S, Kontogianni M, Perrea D, Dimosthenopoulos C, et al. The effect of a non-intensive community- based lifestyle intervention on the prevalence of Metabolic Syndrome. The DEPLAN study in Greece. Hormones (Athens). 2012;11:316–24.CrossRef Makrilakis K, Grammatikou S, Liatis S, Kontogianni M, Perrea D, Dimosthenopoulos C, et al. The effect of a non-intensive community- based lifestyle intervention on the prevalence of Metabolic Syndrome. The DEPLAN study in Greece. Hormones (Athens). 2012;11:316–24.CrossRef
25.
go back to reference Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142(8):611–9.CrossRef Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142(8):611–9.CrossRef
26.
go back to reference Schwalm JD, McCready T, Lopez-Jaramillo P, et al. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomized controlled trial. Lancet. 2019;394:1231–42.CrossRef Schwalm JD, McCready T, Lopez-Jaramillo P, et al. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomized controlled trial. Lancet. 2019;394:1231–42.CrossRef
27.
go back to reference Cargo M, Mercer SL. The value and challenges of participatory research: Strengthening its practice. Ann Rev Public Health. 2008;29:325–50 PubMed.CrossRef Cargo M, Mercer SL. The value and challenges of participatory research: Strengthening its practice. Ann Rev Public Health. 2008;29:325–50 PubMed.CrossRef
28.
29.
go back to reference Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.CrossRef Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.CrossRef
30.
go back to reference World Health Organization. Global Status Report on Non-communicable diseases. Geneva: Switzerland; 2011. World Health Organization. Global Status Report on Non-communicable diseases. Geneva: Switzerland; 2011.
31.
go back to reference World Health Organization. Global Recommendations on Physical Activity for Health 18–64 years old. Geneva: Switzerland; 2011. World Health Organization. Global Recommendations on Physical Activity for Health 18–64 years old. Geneva: Switzerland; 2011.
32.
go back to reference World Health Organization. The WHO STEP-wise approach to non-communicable disease risk factor surveillance (STEPS). 2017. Geneva, Switzerland. World Health Organization. The WHO STEP-wise approach to non-communicable disease risk factor surveillance (STEPS). 2017. Geneva, Switzerland.
33.
go back to reference Onvani Sh, Haghighatdoost F, Azadbakht L. Dietary approach to stop hypertension (DASH): diet components may be related to lower prevalence of different kinds of cancer: a review on the related documents. J Res Med Sci. 2015;20:708–13. Onvani Sh, Haghighatdoost F, Azadbakht L. Dietary approach to stop hypertension (DASH): diet components may be related to lower prevalence of different kinds of cancer: a review on the related documents. J Res Med Sci. 2015;20:708–13.
34.
go back to reference World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks.2009. Geneva, Switzerland. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks.2009. Geneva, Switzerland.
35.
go back to reference World Health Organization. Global Physical Activity Questionnaire (GPAQ) Analysis Guide. Surveillance and Population-Based Prevention of Noncommunicable Diseases. 2002. Geneva, Switzerland World Health Organization. Global Physical Activity Questionnaire (GPAQ) Analysis Guide. Surveillance and Population-Based Prevention of Noncommunicable Diseases. 2002. Geneva, Switzerland
36.
go back to reference World Health Organization Western Pacific Region. International Association for the Study of Obesity, International Obesity Task Force: The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Sydney: Health Communications Australia; 2000. World Health Organization Western Pacific Region. International Association for the Study of Obesity, International Obesity Task Force: The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Sydney: Health Communications Australia; 2000.
37.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.CrossRef Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.CrossRef
38.
go back to reference World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. 2013. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. 2013.
39.
go back to reference Gerstel E, Pataky Z, Busnel C, Rutschmann O, Guessous I, Zumwald C, et al. Impact of lifestyle intervention on body weight and the metabolic syndrome in home-care providers. Diabetes Metab. 2013;2013(39):78–84.CrossRef Gerstel E, Pataky Z, Busnel C, Rutschmann O, Guessous I, Zumwald C, et al. Impact of lifestyle intervention on body weight and the metabolic syndrome in home-care providers. Diabetes Metab. 2013;2013(39):78–84.CrossRef
40.
go back to reference Shehu A, Toti F, Carcani M, Lapardhaja A, Tare R. The prevalence of metabolic syndrome and its relation to metabolic control in patient with diagnosed type 2 Diabetes. 2017 Shehu A, Toti F, Carcani M, Lapardhaja A, Tare R. The prevalence of metabolic syndrome and its relation to metabolic control in patient with diagnosed type 2 Diabetes. 2017
41.
go back to reference Muchiri JW, Gericke GJ, Rheeder P. Effect of a nutrition education programme on clinical status and dietary behaviours of adults with type 2 diabetes in a resource-limited setting in South Africa: a randomised controlled trial. Public Health Nutr. 2015;19:1–14. Muchiri JW, Gericke GJ, Rheeder P. Effect of a nutrition education programme on clinical status and dietary behaviours of adults with type 2 diabetes in a resource-limited setting in South Africa: a randomised controlled trial. Public Health Nutr. 2015;19:1–14.
42.
go back to reference Askari F, Rabiei S, Rastmanesh R. The Effects of Nutrition Education and Diet Therapy on Glycemic and Lipidemic Control in Iranian Patients with Type 2 Diabetes.2013; 3. Askari F, Rabiei S, Rastmanesh R. The Effects of Nutrition Education and Diet Therapy on Glycemic and Lipidemic Control in Iranian Patients with Type 2 Diabetes.2013; 3.
43.
go back to reference Nazaimoon W, Mohamud W, Ismail A, Sharifuddin A. Prevalence of metabolic syndrome and its risk factors in adult Malaysians: Results of a nationwide survey. Diabetes Res Clin Pract. 2011;96:91–7. Nazaimoon W, Mohamud W, Ismail A, Sharifuddin A. Prevalence of metabolic syndrome and its risk factors in adult Malaysians: Results of a nationwide survey. Diabetes Res Clin Pract. 2011;96:91–7.
44.
go back to reference Chang S-H, Chien N-H, Ching-Yi Yu. Long-term lifestyle intervention in elderly with metabolic syndrome. J Clin Nurs. 2019;28(6):658–75.CrossRef Chang S-H, Chien N-H, Ching-Yi Yu. Long-term lifestyle intervention in elderly with metabolic syndrome. J Clin Nurs. 2019;28(6):658–75.CrossRef
45.
go back to reference Chang S-H, Chen M-C, Chien N-H, Lin H-F. Effectiveness of community-based exercise intervention programme in obese adults with metabolic syndrome. J Clin Nurs. 2016;25(17–18):2579–89.CrossRef Chang S-H, Chen M-C, Chien N-H, Lin H-F. Effectiveness of community-based exercise intervention programme in obese adults with metabolic syndrome. J Clin Nurs. 2016;25(17–18):2579–89.CrossRef
46.
go back to reference Azizi F, Mirmiran P, Momenan AA, Hadaegh F, Members of Tehran Lipid and Glucose Study Group. The Effect of Community-Based Education for Lifestyle Intervention on the Prevalence of Metabolic Syndrome and Its Components: Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2013;11(3):145–53.CrossRef Azizi F, Mirmiran P, Momenan AA, Hadaegh F, Members of Tehran Lipid and Glucose Study Group. The Effect of Community-Based Education for Lifestyle Intervention on the Prevalence of Metabolic Syndrome and Its Components: Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2013;11(3):145–53.CrossRef
49.
go back to reference Choi J-H, Woo HD, Lee J-H, Kim J. Dietary patterns and risk for metabolic syndrome in Korean women: a cross-sectional study. Medicine. 2015;94(34):e1424.CrossRef Choi J-H, Woo HD, Lee J-H, Kim J. Dietary patterns and risk for metabolic syndrome in Korean women: a cross-sectional study. Medicine. 2015;94(34):e1424.CrossRef
50.
go back to reference Firouzeh Sajjadi, Mojgan Gharipour, Noushin Mohammadifard, Fatemeh Nouri, Maryam Maghroun, Hasan Alikhasi. Relationship between legumes consumption and metabolic syndrome: Findings of the Isfahan Healthy Heart Program. ARYA Atheroscler. 2014; 10 (1). Firouzeh Sajjadi, Mojgan Gharipour, Noushin Mohammadifard, Fatemeh Nouri, Maryam Maghroun, Hasan Alikhasi. Relationship between legumes consumption and metabolic syndrome: Findings of the Isfahan Healthy Heart Program. ARYA Atheroscler. 2014; 10 (1).
51.
go back to reference Li H, Li X, Yuan S, Jin Y, Jinping Lu. Nut consumption and risk of metabolic syndrome and overweight/obesity: a meta-analysis of prospective cohort studies and randomized trials. Nutr Metab. 2018;15:46.CrossRef Li H, Li X, Yuan S, Jin Y, Jinping Lu. Nut consumption and risk of metabolic syndrome and overweight/obesity: a meta-analysis of prospective cohort studies and randomized trials. Nutr Metab. 2018;15:46.CrossRef
52.
go back to reference Jayalath VH, de Souza RJ, Sievenpiper JL, et al. Effect of dietary pulses on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Am J Hypertens. 2014;27:56–64.CrossRef Jayalath VH, de Souza RJ, Sievenpiper JL, et al. Effect of dietary pulses on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Am J Hypertens. 2014;27:56–64.CrossRef
55.
go back to reference Liu Y, Han Y, Shi J, Li R, Li S, Jin N, et al. Effect of peer education on self-management and psychological status in type-2 diabetes patients with emotional disorders. 2015; 6: 479–86. Liu Y, Han Y, Shi J, Li R, Li S, Jin N, et al. Effect of peer education on self-management and psychological status in type-2 diabetes patients with emotional disorders. 2015; 6: 479–86.
56.
go back to reference Muchiri JW, Gericke GJ, Rheeder P. Effect of nutrition education on diabetes knowledge and attitudes of adults with type 2 diabetes living in a resource limited setting in South Africa: a randomised controlled trial Impact of nutrition education on diabetes knowledge and attitudes of adul. J Endocrinol Metab Diabetes South Africa. 2016;21:26–34.CrossRef Muchiri JW, Gericke GJ, Rheeder P. Effect of nutrition education on diabetes knowledge and attitudes of adults with type 2 diabetes living in a resource limited setting in South Africa: a randomised controlled trial Impact of nutrition education on diabetes knowledge and attitudes of adul. J Endocrinol Metab Diabetes South Africa. 2016;21:26–34.CrossRef
58.
go back to reference Stone NJ, Bilek S, Rosenbaum S. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Am J Cardiol. 2005;96(4A):53E-59E.CrossRef Stone NJ, Bilek S, Rosenbaum S. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Am J Cardiol. 2005;96(4A):53E-59E.CrossRef
59.
go back to reference Visioli, F. Nutritional support in the pharmacological treatment of metabolic syndrome. Eur J Pharmacol. 2011; 668: S43-S49. Visioli, F. Nutritional support in the pharmacological treatment of metabolic syndrome. Eur J Pharmacol. 2011; 668: S43-S49.
61.
go back to reference Hu FB. Physical Activity, Sedentary Behaviors, and Obesity. In: Hu FB, editor. Obesity Epidemiology. New York: Oxford University Press; 2008. p. 301–19.CrossRef Hu FB. Physical Activity, Sedentary Behaviors, and Obesity. In: Hu FB, editor. Obesity Epidemiology. New York: Oxford University Press; 2008. p. 301–19.CrossRef
62.
go back to reference Wennberg M, Gustafsson PE, Wennberg P, et al. Poor breakfast habits in adolescence predict the metabolic syndrome in adulthood. Public Health Nutr. 2015;18(1):122–9.CrossRef Wennberg M, Gustafsson PE, Wennberg P, et al. Poor breakfast habits in adolescence predict the metabolic syndrome in adulthood. Public Health Nutr. 2015;18(1):122–9.CrossRef
63.
go back to reference Després JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039–49.CrossRef Després JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039–49.CrossRef
64.
go back to reference Guzman M, Zbella E, Shah Alvarez S, Nguyen JL, Imperial E, Troncale FJ, Holub C, Mallhi AK, Van Wyk S. Effect of an intensive lifestyle intervention on the prevalence of metabolic syndrome and its components among overweight and obese adults. J Public Health. 2019;42(4):828–38. https://doi.org/10.1093/pubmed/fdz170.CrossRef Guzman M, Zbella E, Shah Alvarez S, Nguyen JL, Imperial E, Troncale FJ, Holub C, Mallhi AK, Van Wyk S. Effect of an intensive lifestyle intervention on the prevalence of metabolic syndrome and its components among overweight and obese adults. J Public Health. 2019;42(4):828–38. https://​doi.​org/​10.​1093/​pubmed/​fdz170.CrossRef
65.
go back to reference Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med. 2010;170:821–7.CrossRef Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med. 2010;170:821–7.CrossRef
Metadata
Title
Community-based lifestyle intervention improves metabolic syndrome and related markers among Kenyan adults
Authors
Okubatsion Tekeste Okube
Samuel Kimani
Waithira Mirie
Publication date
21-03-2022
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2022
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-022-01023-1

Other articles of this Issue 1/2022

Journal of Diabetes & Metabolic Disorders 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare